Skip to main content
Healthcare professional wearing scrubs and a mask smiles into the camera.

Accelerating possibilities

When we challenge inequities, we advance health care possibilities for people and communities.

Our commitment to improving patient outcomes inspires us to address global health disparities. We collaborate with partners outside the company to expand community education, increase health care provider outreach and break down barriers to care.

Two women wearing Boston Scientific shirts at an outdoor health fair smile while one holds up a medical device.

Our priorities

2022 highlights

Our teams deepened their collaboration with nongovernmental organizations, nonprofits, health care advocates and providers to address health inequities in underrepresented populations.


women and people of color identified in health action plans to advance equitable care in underserved  U.S. communities

$67 million

donated to fund medical research, fellowships, education and charitable organizations globally

Older dark-skinned female patient sits at a table looking into the camera.

ELEGANCE drives critical clinical insights for underrepresented patient populations

Approximately 200 million people around the world are affected by peripheral artery disease, a common circulatory problem that disproportionately affects Black men and women. Clinical studies for the disease typically do not include the common patient populations affected by the disease.

As of 2022, Boston Scientific’s ELEGANCE registry is currently exceeding its goal to increase the representation of women and underrepresented minorities in clinical trials to better reflect the populations affected by peripheral artery disease. Current enrollment spans 46 global sites and includes 43% women and 47% underrepresented minorities.

“Increasing diversity in medical research is a critical step to ensure that everyone can benefit from treatments and therapies. Now is the time to eliminate disparities in health care — once and for all.”

– Michael R. Jaff, D.O., chief medical officer and vice president, clinical affairs, technology and intervention, Peripheral Interventions

Headshot of Michael R Jaff DO Chief Medical Officer and Vice President of Clinical Affiars Technology and Intervention Peripheral Interventions.


Explore our progress

Learn more about our 2022 progress in working towards health equity. 

Our awards

Boston Scientific is proud to be recognized for our health care innovations that impact patients' lives.


Best Employers for Diversity 



World’s Most Admired Companies


JUST Capital and CNBC’s

America’s Most JUST Companies


All data as of December 31, 2022 unless otherwise noted.